All Issue

2020 Vol.33, Issue 6 Preview Page

Research Article

1 December 2020. pp. 659-665
Abstract
References
1
Birrell, M.A., E. Hardaker, S. Wong, K. McCluskie, M. Catley, J. De Alba, R. Newton, S. Haj-Yahia, K.T. Pun, C.J. Watts, R.J. Shaw, T.J. Savage and M.G. Belvisi. 2005. Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am. J. Respir. Crit. Care Med. 172:962-971. 10.1164/rccm.200412-1647OC16002568
2
Bouchier-Hayes, L. and S.J. Martin. 2004. CARDINAL roles in apoptosis and NFkappaB activation. Vitam. Horm. 67:133-147. 10.1016/S0083-6729(04)67008-7
3
Caughey, G.H. 2016. Mast cell proteases as pharmacological targets. Eur. J. Pharmacol. 778:44-55. 10.1016/j.ejphar.2015.04.04525958181PMC4636979
4
DiDonato, J.A., F. Mercurio and M. Karin. 2012. NF-κB and the link between inflammation and cancer. Immunol. Rev. 246:379-400. 10.1111/j.1600-065X.2012.01099.x22435567
5
Edwards, M.R., K. Strong, A. Cameron, R.P. Walton, D.J. Jackson and S.L. Johnston. 2017. Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness. J. Allergy Clin. Immunol. 140:909-920. 10.1016/j.jaci.2017.07.02528987220PMC7173222
6
Furue, M. and T. Kadono. 2017. "Inflammatory skin march" in atopic dermatitis and psoriasis. Inflamm. Res. 66:833-842. 10.1007/s00011-017-1065-z28620798
7
Gilmore, T.D. and M.R. Garbati. 2011. Inhibition of NF-κB signaling as a strategy in disease therapy. Curr. Top. Microbiol. Immunol. 349: 245-263. 10.1007/82_2010_10521113699
8
Han, N.R., P.D. Moon, N.R. Kim, H.Y. Kim, H.J. Jeong and H.M. Kim. 2017. Schisandra chinensis and its main constituent schizandrin attenuate allergic reactions by down-regulating caspase-1 in ovalbumin-sensitized mice. Am. J. Chin. Med. 45:159-172. 10.1142/S0192415X1750011228081628
9
Hawiger, J. 2001. Innate immunity and inflammation: A transcriptional paradigm. Immunol. Res. 23:99-109. 10.1385/IR:23:2-3:099
10
Kim, H.J. and S.H. Kang. 2017. Ethnobotany, phytochemistry, pharmacology of the Korean Campanulaceae: A comprehensive review. Korean J. Plant Res. 30:240-264. 10.7732/kjpr.2017.30.2.240
11
Kim, H.Y., S.Y. Nam, S.Y. Hwang, H.M. Kim and H.J. Jeong. 2016. Atractylone, an active constituent of KMP6, attenuates allergic inflammation on allergic rhinitis in vitro and in vivo models. Mol. Immunol. 78:121-132. 10.1016/j.molimm.2016.09.00727636508
12
Kim, J.Y., K.W. Park, K.D. Moon, M.K. Lee, J. Choi, S.T. Yee, K.H. Shim and K.I. Seo. 2008. Induction of apoptosis in HT-29 colon cancer cells by crude saponin from Platycodi Radix. Food Chem. Toxicol. 46:3753-3758. 10.1016/j.fct.2008.09.06718955103
13
Kim, S.J., M.C. Kim, J.Y. Um and S.H. Hong. 2010. The beneficial effect of vanillic acid on ulcerative colitis. Molecules 15:7208-7217. 10.3390/molecules1510720820959795PMC6259113
14
Kuida, K., J.A. Lippke and G. Ku. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin‐1B converting enzyme. Science 267:2000-2002. 10.1126/science.75354757535475
15
Lamkanfi, M., M. Kalai, X. Saelens, W. Declercq and P. Vandenabeele. 2004. Caspase-1 activates nuclear factor of the kappa-enhancer in B cells independently of its enzymatic activity. J. Biol. Chem. 279:24785-24793. 10.1074/jbc.M40098520015039421
16
Lee, Y.S., S.B. Han, H.J. Ham, J.H. Park, J.S. Lee, D.Y. Hwang, Y.S. Jung, D.Y. Yoon and J.T. Hong. 2020. IL-32γ suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B. J. Allergy Clin. Immunol. 146:156-168. 10.1016/j.jaci.2019.12.90531931018
17
Li, J.W., Y. Liu, B.H. Li, Y.Y. Wang, H. Wang and C.L. Zhou. 2016. A polysaccharide purified from Radix Adenophorae promotes cell activation and pro-inflammatory cytokine production in murine RAW264.7 macrophages. Chin. J. Nat. Med. 14:370-376.
18
Lim, J.M., B. Lee, J.H. Min, E.Y. Kim, J.H. Kim, S. Hong, J.J. Kim, Y. Sohn and H.S. Jung. 2018. Effect of peiminine on DNCB-induced atopic dermatitis by inhibiting inflammatory cytokine expression in vivo and in vitro. Int. Immunopharmacol. 56:135-142. 10.1016/j.intimp.2018.01.02529414643
19
Martin, R.A., J.L. Ather, L.K. Lundblad, B.T. Suratt, J.E. Boyson, R.C. Budd, J.F. Alcorn, R.A. Flavell, S.C. Eisenbarth and M.E. Poynter. 2013. Interleukin-1 receptor and caspase-1 are required for the Th17 response in nitrogen dioxide-promoted allergic airway disease. Am. J. Respir. Cell Mol. Biol. 48:655-664. 10.1165/rcmb.2012-0423OC23371061PMC3707382
20
Mitchell, J.P. and R.J. Carmody. 2018. NF-κB and the transcriptional control of inflammation. Int. Rev. Cell Mol. Biol. 335:41-84. 10.1016/bs.ircmb.2017.07.00729305014
21
Modena, B.D., K. Dazy and A.A. White. 2016. Emerging concepts: mast cell involvement in allergic diseases. Transl. Res.174: 98-121. 10.1016/j.trsl.2016.02.01126976119
22
Sakamoto, T., W. Ohashi, K. Tomita , K. Hattori , N. Matsuda and Y. Hattori. 2018. Anti-inflammatory properties of cilostazol: Its interruption of DNA binding activity of NF-kappaB from the Toll-like receptor signaling pathways. Int Immunopharmacol. 62:120-131. 10.1016/j.intimp.2018.06.02130005227
23
Siegmund, B., H.A. Lehr, G. Fantuzzi and C.A. Dinarello. 2001. IL-1 betaconverting enzyme (caspase-1) in intestinal inflammation. PNASU. 98:13249-13254. 10.1073/pnas.23147399811606779PMC60856
24
Song, P., J. Xia, C. Rezeng, L. Tong and W. Tang. 2016. Traditional, complementary, and alternative medicine: Focusing on research into traditional Tibetan medicine in China. Biosci. Trends 10:163-170. 10.5582/bst.2016.0110527301588
25
Theoharides, T.C., I. Tsilioni and H. Ren. 2019. Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders? Expert Rev. Clin. Immunol. 15:639-656. 10.1080/1744666X.2019.159680030884251PMC7003574
Information
  • Publisher :The Plant Resources Society of Korea
  • Publisher(Ko) :한국자원식물학회
  • Journal Title :Korean Journal of Plant Resources
  • Journal Title(Ko) :한국자원식물학회지
  • Volume : 33
  • No :6
  • Pages :659-665
  • Received Date : 2020-09-16
  • Revised Date : 2020-11-20
  • Accepted Date : 2020-11-25